Sarver Vrooman Wealth Advisors
Position in BMY — Bristol Myers Squibb Co
CIK 2076215
KANSAS CITY, MO
Position in BMY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$43,042
-$3,476 QoQ
Shares Held
747
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,339
of 2,506 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sarver Vrooman Wealth Advisors holds $412,483 across 5 Drug Manufacturers - General names. BMY ranks #5 (10.4% of the industry book) .
All Filings in BMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,042 | 747 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $46,518 | 767 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $39,861 | 739 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $53,443 | 1,185 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $54,853 | 1,185 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $79,835 | 1,309 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||